跳至主要内容
临床试验/NCT01276431
NCT01276431已完成4 期

Norspan Efficacy and Safety Among Elderly Subjects

Mundipharma AB2 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2011年3月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
102
试验地点
2
主要终点
Box Scale-11 (BS-11) pain scores (pain on average during the last seven days, mean change from Baseline to Completion (fulfilled all visits in the study).

研究概览

简要总结

An open label, multi-centre, prospective age-group-controlled study to evaluate efficacy and safety of buprenorphine transdermal patches in subjects with chronic, moderate to severe osteoarthritis pain of the hip and/or knee.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Buprenorphine transdermal patch

Other

For two age groups: 50-60 years and >= 75 years of age

干预措施: Buprenorphine transdermal patch (Drug)

结局指标

主要结局

Box Scale-11 (BS-11) pain scores (pain on average during the last seven days, mean change from Baseline to Completion (fulfilled all visits in the study).

次要结局

  • Western Ontario & McMaster Universities OA Index
  • European QOL Health Questionnaire
  • Sleep disturbance & quality of sleep questions
  • Patients global assessment of pain relief
  • Investigators global assessment of pain relief
  • Incidence of rescue medication

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验